N-Acetylmuramate



Compound IDCDAMM00110
Common nameN-Acetylmuramate
IUPAC name(2R)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid
Molecular formulaC11H19NO8

Experimental data

Retention time60.82
Adduct[M+H]+
Actual mz294.117
Theoretical mz294.118
Error2.85
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.5595

Identifiers and class information

Inchi keyMNLRQHMNZILYPY-FTNICRTINA-N
SmilesCC(C(=O)O)OC1C(C(OC(C1O)CO)O)NC(=O)C
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)1
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)293.273
Computed dipole moment(dipole)9.408
Total solvent accessible surface area (SASA)515.969
Hydrophobic component of SASA (FOSA)273.036
Hydrophilic component of SASA (FISA)242.933
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)891.757
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)13
Free energy of solvation of dipole (dip^2/V)0.0992582
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0563385
Globularity descriptor (glob)0.868372
Predicted polarizability in cubic angstroms (QPpolrz)24.397
Predicted hexadecane/gas partition coefficient (QPlogPC16)9.376
Predicted octanol/gas partition coefficient (QPlogPoct)23.479
Predicted water/gas partition coefficient (QPlogPw)23.178
Predicted octanol/water partition coefficient (QPlogPo/w)-2.01
Predicted aqueous solubility (QPlogS)-0.525
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.068
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-0.48
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)7.227
Predicted brain/blood partition coefficient (QPlogBB)-2.066
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)5.502
Predicted skin permeability, log Kp (QPlogKp)-5.229
PM3 calculated ionization potential (IP(ev))9.664
PM3 calculated electron affinity (EA(eV))-0.57
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)-1.573
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)30.552
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)29.749
Van der Waals surface area (PSA)163.913
Number of nitrogen and oxygen atoms (#NandO)9
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P16278GLB1Beta-galactosidase (by homology)T73134SEA
Q9BZP6CHIAAcidic mammalian chitinase (by homology)T51597SEA
P32320CDACytidine deaminase (by homology)T79027SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P52789HK2Hexokinase type IIT96685SEA
P16109SELPP-selectinT10965SEA
P17931LGALS3Galectin-3T72038SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA
P20916MAGMyelin-associated glycoprotein (by homology)T95286SEA
P09382LGALS1Galectin-1T09544SEA
Q07108CD69Early activation antigen CD69T48780SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T73134DI0242Lysosomal disease[ICD-11: 5C56]P16278GLB1
T79027DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P32320CDA
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T96685DI0133Epidermal dysplasias[ICD-11: EK90]P52789HK2
T10965DI0088Circulatory system disease[ICD-11: BE2Z]P16109SELP
T10965DI0381Sickle-cell disorder[ICD-11: 3A51]P16109SELP
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T95286DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P20916MAG

Copyright © 2025